Figure 1From: Allogeneic bone marrow transplantation can suppress established and otherwise chronic collagen-induced arthritis after a nonmyeloablative conditioning regimen employing anti-CD40 ligand monoclonal antibodyAllogeneic BMT can suppress both clinical disease and pathogeneic antibodies. (a) Clinical disease over time. (b) Anti-type II collagen antibodies are decreased after treatment.Back to article page